Cancer care in Sweden

The quality of cancer care in Sweden is high and survival rates for many types of cancer are above the European average. Although the economic and social impact of cancer on society is lower than the European average, Sweden spends more than an average European country on cancer treatment relative to its incidence. Cancer therefore continues to represent a substantial economic and social cost.

All.Can Sweden initiative

The aim of the initiative is to improve cancer care and to create sustainable and equal conditions for the care of all cancer patients in Sweden. The initiative aims at developing proposals for improvements in Swedish cancer care, in dialogue with patient organisations, healthcare representatives, researchers, politicians and representatives from the health technology sector. The initiative strives to improve cancer prevention, diagnosis and treatment, as well as rehabilitation. A previous effort of All.Can in Sweden resulted in the Report “Swedish National Cancer Plan 2020 – improved access and reduced mortality.

Cancerorganisationen All.Can International publicerar policyplan: Building Efficiency in cancer care

    All.Can International har publicerat en plan, “Building Efficiency in Cancer Care” – för att stödja åtgärder som syftar till att cancervården blir mer jämlik och individanpassad. Rapporten visar på vikten av att satsa på innovationer och strategiska investeringar för att skapa effektivitetsvinster på…

Read more

Contact

Secretariat: Hallvarsson & Halvarsson

rita.nimborn@halvarsson.se

Spokesperson

Emma Henriksson

Steering Committee

Margareta Haag

Nätverket mot Cancer

Maude Andersson

The European Cancer Patient Coalition

Susanne Dieroff Hay

Bröstcancerförbundet

Emma Tonnes

Ung Cancer

Ebba Hallersjö Hult

Stockholm School of Economics | Vision Zero Cancer at House of Innovation

Mathias Ekman

Microsoft

Kjell Bergfeldt

Skandionkliniken

Ewa Carlsson

Nätverket mot cancer

Sponsoring Members

Jonas Edström

Roche

Jessica Lundström

Bristol Myers Squibb

Linda Svensson

Bristol Myers Squibb

Cancerorganisationen All.Can International publicerar policyplan: Building Efficiency in cancer care

    All.Can International har publicerat en plan, “Building Efficiency in Cancer Care” – för att stödja åtgärder som syftar till att cancervården blir mer jämlik och individanpassad. Rapporten visar…

All.Can: Building efficiency in cancer care

  All.Can: Building efficiency in cancer care Välkommen till ett seminarium som All.Can international arrangerar, Den nya All.Can-policyuppmaning “Building efficiency in cancer care” för bättre resultat för patienter och ett…

Seminarium: Användning av hälsodata – kan patienten vänta?

  Användning av hälsodata – kan patienten vänta? Om eventet: Forskning och uppföljning med hjälp av hälsodata är centralt för att säkerställa att svenska cancerpatienter får tillgång till rätt behandlingar…

All.Can Sweden patient survey

All.Can Sweden launched the results from its patient survey in September 2021. Main finding: Early and correct cancer diagnosis correlates with a better experience of the total care. The survey…

All.Can Sweden – Launch Webinar

All.Can Sweden launch webinar took place on December 3rd 2020.  To see the webinar, please click on the following link (Swedish only): https://www.netigate.se/a/s.aspx?s=932664X253007948X2711

 

 

 

 

 

 

All.Can Sweden patient survey

All.Can Sweden launched the results from its patient survey in September 2021.
Main finding: Early and correct cancer diagnosis correlates with a better experience of the total care. The survey is available in Swedish.

 

Older reports

All.Can Sweden policy report

All.Can Sweden launched its policy report in June 2018. National Cancer Plan 2020: Improved access and reduced mortality – it is time to escalate the fight against cancer! is available in Swedish, with a summary version available in English.

Disclaimer:

The All.Can initiative is made up of leading representatives of patient organisations, policymakers, healthcare professionals, science and industry. All the publications produced as part of this initiative reflect a consensus of All.Can members, who retain full editorial control.

The All.Can initiative in Sweden is supported by Bristol Myers Squibb and Roche. None of the content developed from All.Can discussions and activities contains direct or indirect references to specific medicinal products or therapies.